Американское общество гирудотерапии

Plantar Warts (Verruca Plantaris, Refractory)

Highly investigational use for refractory plantar warts (HPV-mediated) after cryotherapy and salicylic acid failure; very limited anecdotal evidence.

Tier C — InvestigationalИсследовательское применениеLast updated: 2026-05-26 · Reviewed by ASH Editorial Board

Краткая информация для пациента

Есть ли FDA-допуск для этого показания?
Not FDA-cleared for plantar warts (verruca plantaris). FDA cleared medicinal leeches only for venous congestion in microsurgical reconstruction (K040187, June 2004). Use here is Tier C investigational.
Какие доказательства существуют?
Tier C (investigational). Anecdotal only. Evidence-based first-line management of plantar warts is salicylic acid keratolytic therapy and cryotherapy (each with ~50-70% cure rates over 12-16 weeks). Refractory warts may respond to topical 5-fluorouracil, intralesional bleomycin, cantharidin, candida antigen injection, or laser ablation. Many plantar warts also resolve spontaneously over 12-24 months.
Основные риски
  • Bleeding from each bite site for 6 to 10 hours after the leech detaches
  • Iron-deficiency anemia from cumulative blood loss across multiple sessions
  • Aeromonas hydrophila wound infection from leech gut bacteria (uncommon outside reconstructive surgery, but possible)
  • Allergic reaction to leech saliva (rare; ranges from local itching to anaphylaxis)
  • Permanent Y-shaped bite-mark scars or hyperpigmentation at attachment sites
  • Local pain, bruising, swelling, or itching for 1 to 3 days after each session
  • Spread of HPV to surrounding skin from disturbing the wart surface
  • Painful prolonged bleeding from a thick keratinized plantar surface that does not seal easily
Кому не следует это рассматривать
  • Patients with diabetes, peripheral arterial disease, or peripheral neuropathy (high foot-ulcer risk)
  • Patients whose warts have not had a proper trial of salicylic acid, cryotherapy, or other standard therapy
  • Anyone on blood thinners such as warfarin, apixaban, rivaroxaban, dabigatran, heparin, or daily aspirin used for medical reasons
  • People with hemophilia or any other inherited bleeding disorder
  • Patients with severe anemia (hemoglobin under 10 g/dL)
  • People with an active infection at the planned application site
  • Patients who are pregnant or breastfeeding (relative contraindication; insufficient safety data)
О чём спросить врача
  • Have I tried salicylic acid for at least 12 weeks?
  • Have I tried cryotherapy for 2-3 sessions?
  • Have intralesional options like bleomycin or candida antigen been considered?
  • What is the published cure rate for leeches versus a 70 percent cure rate for standard therapy?
  • What is the bleeding-control plan on the bottom of the foot, where dressings shift with walking?
  • How will viral spread to other foot skin be prevented?
Когда срочно обратиться за медицинской помощью
  • Bleeding from a bite site that soaks through more than one dressing per hour
  • Bleeding that continues more than 24 hours after the leech detached
  • Spreading redness, warmth, swelling, pus, or red streaks around any bite site
  • Fever over 38.0 C / 100.4 F, chills, or feeling suddenly unwell after a session
  • Hives, facial or tongue swelling, throat tightness, or any difficulty breathing
  • Sudden weakness, dizziness, fast heart rate, or fainting (possible severe blood loss)
  • Inability to bear weight on the foot due to pain or new wound
  • Spreading streaks of redness up the foot or leg

Что это НЕ означает

  • It does not mean leech therapy is FDA-cleared for plantar warts — the only FDA clearance is venous congestion in microsurgical reconstruction (K040187, June 2004).
  • It does not replace standard therapy: salicylic acid, cryotherapy, and (for refractory cases) intralesional injections or laser.
  • It does not eliminate the underlying HPV infection that caused the wart.
  • It does not prevent recurrence at the same or new sites.
  • It does not have controlled-trial evidence for this indication.

Перекрёстные ссылки безопасности

Clinical Profile

Category
dermatological
ICD-10
B07.0, B07.9
Safety tier
low

Evidence Summary

Plantar warts are HPV-mediated benign epithelial proliferations conventionally treated with topical salicylic acid (~60% efficacy) and cryotherapy (~50% efficacy), with second-line options including intralesional bleomycin or candida antigen, pulsed dye laser, or surgical paring with cantharidin. Direct evidence for leech therapy is limited to a single case report describing clearance of a longstanding giant plantar wart after medicinal leech application in an immunosuppressed patient; this is grade D anecdotal evidence, not a case series, and the mechanism is unclear (possible local immune stimulation). Most plantar warts resolve spontaneously over 1-2 years.

Treatment specifics

How many leeches, where they are placed, how long a session lasts, and whether to repeat are clinical decisions made by a qualified provider under institutional protocol — not something to self-administer. Discuss the specifics with a clinician experienced in medicinal leech therapy. (Clinicians: switch the audience selector in the top bar to “Clinician” to view protocol detail.)

Key Trials

  1. Singh K et al. (2020), n=12

Contraindications

  • Active anticoagulant therapy (warfarin INR >2.0, DOACs, heparin)
  • Hemophilia or other bleeding disorder
  • Severe anemia (Hb <10 g/dL)
  • Active bacteremia or sepsis
  • Known hypersensitivity to leech salivary proteins
  • Pregnancy (relative — first/third trimester)
  • Immunocompromised state with severe neutropenia
  • Mosaic warts covering >5 cm area (immune-targeted therapy preferred)
  • Diabetic foot or peripheral neuropathy
  • Immunocompromise predisposing to HPV proliferation
  • Suspected verrucous carcinoma (biopsy required)

Related Conditions

Этот сайт предоставляет образовательную информацию и не является медицинской консультацией, диагнозом или рекомендацией по лечению. Гирудотерапия сопряжена с клинически значимыми рисками и должна проводиться только квалифицированными клиницистами в рамках институционально утверждённых протоколов. Разрешение FDA 510(k) для медицинских пиявок ограничено определёнными показаниями; обсуждения исследовательского и нелицензионного применения отмечены соответствующим образом. Для индивидуальных медицинских рекомендаций обратитесь к квалифицированному медицинскому специалисту.

Plantar Warts (Verruca Plantaris, Refractory) — Hirudotherapy Evidence | ASH